Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 18Terminated 3Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Other 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Obesity 1Neurofibromatosis 1 1Neoplasm, Residual 1Neoplasm Metastasis 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Disease Progression 1Bone Diseases 1

Interventions

Trastuzumab 78Capecitabine 59Cyclophosphamide 54Paclitaxel 52Docetaxel 50Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 26exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Taxes 17Everolimus 17Epirubicin 15pertuzumab 13Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13palbociclib 12Magnetic Resonance Spectroscopy 12liposomal doxorubicin 11atezolizumab 11Filgrastim 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Vitamin D × Clear all
NCT01472445 2026-04-23

Vitamin D and Breast Cancer: Does Weight Make a Difference?

Stanford University

Phase 2 Terminated
41 enrolled 16 charts
BreastOther

Breast Neoplasms, Obesity

NCT02795572 2019-07-05

CIPN

AHS Cancer Control Alberta

Phase 2 Terminated
13 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT00904423 2017-02-14

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Stanford University

Phase 1/2 Terminated
8 enrolled 4 charts
Breast

Bone Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡